
Cibus Inc (CBUS) Stock Forecast & Price Target
Cibus Inc (CBUS) Analyst Ratings
Bulls say
Cibus Inc. is anticipating near-term revenues of $3-5 million from contract research collaborations during 2024-2026, signaling a critical phase for the company as it establishes its revenue base. A substantial revenue growth is projected, with trait royalty revenues expected to increase significantly from $48.2 million in 2027 to $0.7 billion by 2034, reflecting a robust seven-year compound annual growth rate (CAGR) of 47.5%. Additionally, Cibus demonstrated improved financial performance with a net gain of $1.5 million, or $0.06 per share, in 3Q24, compared to a net loss in the prior quarter, indicating a positive shift in the company's financial health.
Bears say
Cibus Inc. is projected to maintain high gross margins of approximately 90% through 2026; however, a decline to 88% is anticipated post-2026 due to the planned donation of 1-2% of revenues exceeding $100 million to its charitable foundation. This reduction in gross margin could affect the company’s profitability as it scales its revenues, potentially constraining available funds for reinvestment or growth initiatives. Furthermore, the financial commitment to charitable contributions may divert critical resources away from business operations, impacting long-term financial sustainability.
This aggregate rating is based on analysts' research of Cibus Inc and is not a guaranteed prediction by Public.com or investment advice.
Cibus Inc (CBUS) Analyst Forecast & Price Prediction
Start investing in Cibus Inc (CBUS)
Order type
Buy in
Order amount
Est. shares
0 shares